These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37314132)

  • 1. Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation?
    Kiyak M; Ayhan R; Yavuz M; Demirtas C; Çakmak S; Altunöz E; İpek S
    Rev Esp Enferm Dig; 2024 Jun; 116(6):336-337. PubMed ID: 37314132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP.
    Leonhardt S; Grajecki D; Geisel D; Fehrenbach U; Adler A; Leonhardt J; Horst D; Kurth F; Thibeault C; Janssen HJ; Kaul T; Faiss S; Tacke F; Jürgensen C
    Am J Gastroenterol; 2024 Apr; 119(4):748-759. PubMed ID: 37843039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection.
    Rela M; Rajakannu M; Veerankutty FH; Vij M; Rammohan A
    Am J Transplant; 2022 Dec; 22(12):3143-3145. PubMed ID: 35929565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for post-COVID-19 cholangiopathy: A case series.
    Sambommatsu Y; Mouch C; Kulkarni AV; Bruno DA; Eslami M; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Morales MK; Montenovo MI; Rao PN; Reddy R; Menon B; Kumaran V
    Clin Transplant; 2023 Dec; 37(12):e15141. PubMed ID: 37755152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.
    Durazo FA; Nicholas AA; Mahaffey JJ; Sova S; Evans JJ; Trivella JP; Loy V; Kim J; Zimmerman MA; Hong JC
    Transplant Proc; 2021 May; 53(4):1132-1137. PubMed ID: 33846012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-acute coronavirus disease 2019 (COVID 19) syndrome:
    Roda S; Ricciardi A; Maria Di Matteo A; Zecca M; Morbini P; Vecchia M; Chiara Pieri T; Giordani P; Tavano A; Bruno R
    Clin Infect Pract; 2022 Jul; 15():100144. PubMed ID: 35498053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 related biliary injury: A review of recent literature.
    Yadlapati S; Jarrett SA; Baik D; Chaaya A
    World J Gastroenterol; 2023 Apr; 29(14):2127-2133. PubMed ID: 37122603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 Cholangiopathy: A Novel Entity.
    Roth NC; Kim A; Vitkovski T; Xia J; Ramirez G; Bernstein D; Crawford JM
    Am J Gastroenterol; 2021 May; 116(5):1077-1082. PubMed ID: 33464757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of COVID-19 cholangiopathy using cholangioscopy-a case report of two critically ill patients.
    Kroepfl V; Treml B; Freund MC; Profanter C
    Eur Surg; 2022; 54(6):326-330. PubMed ID: 36189108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-COVID-19 Cholestasis: A Case Series and Review of Literature.
    Kulkarni AV; Khelgi A; Sekaran A; Reddy R; Sharma M; Tirumalle S; Gora BA; Somireddy A; Reddy J; Menon B; Reddy DN; Rao NP
    J Clin Exp Hepatol; 2022; 12(6):1580-1590. PubMed ID: 35719861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-COVID-19 cholangiopathy: Current understanding and management options.
    Veerankutty FH; Sengupta K; Vij M; Rammohan A; Jothimani D; Murali A; Rela M
    World J Gastrointest Surg; 2023 May; 15(5):788-798. PubMed ID: 37342848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID cholangiopathy: A narrative review.
    Caballero-Alvarado J; Zavaleta Corvera C; Merino Bacilio B; Ruiz Caballero C; Lozano-Peralta K
    Gastroenterol Hepatol; 2023; 46(6):474-482. PubMed ID: 36174796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.
    Steiner J; Kaufmann-Bühler AK; Fuchsjäger M; Schemmer P; Talakić E
    World J Gastrointest Surg; 2022 Dec; 14(12):1411-1417. PubMed ID: 36632122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy.
    Chirichella TJ; Dunham CM; Zimmerman MA; Phelan EM; Mandell MS; Conzen KD; Kelley SE; Nydam TL; Bak TE; Kam I; Wachs ME
    World J Gastroenterol; 2016 Mar; 22(12):3392-403. PubMed ID: 27022221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary sclerosing cholangitis after critical COVID-19: Three case reports.
    Mayorquín-Aguilar JM; Lara-Reyes A; Revuelta-Rodríguez LA; Flores-García NC; Ruiz-Margáin A; Jiménez-Ferreira MA; Macías-Rodríguez RU
    World J Hepatol; 2022 Aug; 14(8):1678-1686. PubMed ID: 36157873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.